Testing effectiveness (Phase 2)Study completedNCT00077922
What this trial is testing
Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia
Who this might be right for
LeukemiaLymphocyticChronic
National Cancer Institute (NCI) 15
Showing 20 of 34 results